PMID: 6404298Mar 1, 1983Paper

Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody

Biochemistry
J Novotnỳ, M N Margolies

Abstract

A hybridoma cell line (26-10) derived from the A/J strain of mice secretes an immunoglobulin (IgG2a-k) which binds digoxin with an association constant of 1.2 nM. Such high-affinity antibodies have been utilized in clinical radioimmunoassays as well as in the reversal of toxicity due to excess digoxin. The amino acid sequence of the light chain variable region of this antibody was derived by automated sequencing of the following: the intact chain; a fragment beginning C terminal to the tryptophan residue 40, obtained by cleavage with iodosobenzoic acid; a fragment beginning C terminal to arginine residue 82, obtained by trypsin cleavage on the completely reduced, alkylated, and succinylated chain. Difficulties which had previously prevented the automated Edman sequencing of this chain (and, presumably, similar ones of the same subgroup) were overcome by increasing the duration of the cleavage step at proline residues 8 and 12. The sequences of the first two hypervariable and framework regions of this chain are virtually identical with those of the dinitrophenol- and menadione-binding myeloma light chain MOPC 460 (95% homology). This anti-digoxin hybridoma from the A/J strain makes use of a Vk gene which is similar to that utili...Continue Reading

References

Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·E HaberL E Cannon
Aug 21, 1979·Biochemistry·W C Mahoney, M A Hermodson
Feb 1, 1978·Analytical Biochemistry·G E TarrD J McKean
Mar 1, 1978·Analytical Biochemistry·D G KlapperJ D Capra
Apr 8, 1976·The New England Journal of Medicine·T W SmithV P Butler
Nov 1, 1976·Hoppe-Seyler's Zeitschrift für physiologische Chemie·W F BrandtC Von Holt
Nov 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·D M SegalD R Davies

❮ Previous
Next ❯

Citations

May 1, 1994·Protein Science : a Publication of the Protein Society·J F SchildbachR I Near
Jan 1, 1987·Immunogenetics·P M HogarthI F McKenzie
Apr 1, 1985·Molecular Immunology·M Mudgett-HunterM N Margolies
Jan 1, 1988·Immunology Today·C SchiffM Fougereau
Apr 28, 1995·Journal of Molecular Biology·P D JeffreyS Sheriff
Dec 1, 1992·Immunological Reviews·E Haber
Feb 1, 1984·Analytical Biochemistry·A W BrauerM N Margolies
Oct 1, 1988·Immunological Reviews·M Fougereau, C Schiff
Jan 1, 1986·Critical Reviews in Clinical Laboratory Sciences·S W Graves

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.